LAVIPHARM S.A. NA EO 1 (BXA0) — Net Asset Momentum
LAVIPHARM S.A. NA EO 1 (BXA0) recorded a net asset momentum of 23.8% as of December 2024, with net assets of €52.97 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See LAVIPHARM S.A. NA EO 1 liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
LAVIPHARM S.A. NA EO 1 Net Asset Momentum (2021–2024)
This chart tracks LAVIPHARM S.A. NA EO 1's year-over-year net asset growth across 4 annual reporting periods from 2021 to 2024. The most recent momentum reading is +23.8%, with net assets of €52.97 Million EUR as of December 2024. Read BXA0 total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for LAVIPHARM S.A. NA EO 1 (2021–2024)
The table below shows the complete annual net asset history for LAVIPHARM S.A. NA EO 1 from 2021 to 2024, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see LAVIPHARM S.A. NA EO 1 (BXA0) market capitalisation.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €52.97 Million | €125.48 Million | €72.52 Million | ▲ +23.8% |
| 2023 | €42.77 Million | €114.79 Million | €72.02 Million | ▲ +6.1% |
| 2022 | €40.31 Million | €114.17 Million | €73.86 Million | ▲ +505.7% |
| 2021 | €-9.94 Million | €52.74 Million | €62.68 Million | — |